Jack Satsangi
1963
-
Articles 154
-
Predicting outcome in acute severe colitis - controversies in clinical practice in 2021
-
Precision medicine in inflammatory bowel disease: concept, progress and challenges
-
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
-
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
-
Real-World Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multi-Centre UK Experience
-
Just another flare of ulcerative colitis?
-
Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanisms
-
Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies
-
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel disease
-
Therapeutic decisions in inflammatory bowel disease in the SARS-Cov-2 pandemic
-
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis
-
COVID-19 and Gastrointestinal Disease. Implications for the Gastroenterologist
-
Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply
-
De-escalation of medical therapy in inflammatory bowel disease
-
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome
-
The type III intermediate filament vimentin regulates organelle distribution and modulates autophagy
-
The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK
-
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study.
-
Blood-based DNA methylation in Crohn's disease and severity of intestinal inflammation
-
Shared activity patterns arising at genetic susceptibility loci reveal underlying genomic and cellular architecture of human disease.
-
Purine metabolism controls innate lymphoid cell function and protects against intestinal injury.
-
Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease.
-
The role of genetics in Crohn's disease: how could it influence future therapies?
-
Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers
-
Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD
-
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation
-
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry
-
Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.
-
Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.
-
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.
-
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
-
Fine-mapping inflammatory bowel disease loci to single-variant resolution
Human - wd:Q28050119